Journal of Liver Cancer

2 "Arterioportal shunt"

Filter

Article category

Publication year

Case Reports

Arterioportal Shunt in Hepatocellular Carcinoma: Jung Won Yun, Yong Kyun Cho, Byung Ik Kim; Journal of the Korean Liver Cancer Study Group. 2004;4(1):16-19. Published online June 30, 2004

Abstract PDF: Arterioportal shunt is an important hemodynamic alteration in the liver, may cause severe portal hypertension, consequently ascites, esophageal varix, or accelerating intra- and/or extravascular metastasis of carcinoma cells. Understanding of these findings will contribute to the diagnosis and prognosis of the disease and improve therapeutic efficacy for the patients. We report a case of hepatocellular carcinoma with arterioportal shunt, which was difficult to treatment.

Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Arterioportal Shunt : A Report of One Case: Sang Kyun Yu, Soon Ho Um, Cheol Young Kim, Sung Bum Cho, Nam Hee Won; Journal of the Korean Liver Cancer Study Group. 2004;4(1):29-32. Published online June 30, 2004

Abstract PDF: Transcatheter arterial chemoembolization(TACE) is an effective treatment method in the management of patients with inoperable hepatocellular carcinoma. The effectiveness of TACE, however, is decreased, when arterioportal shunt is present, since embolic and chemotherapeutic agents are diverted from the tumor to the normal parenchyma through branches of the portal vein. In such case, TACE may not only be ineffective, but also cause hepatic infarction followed by hepatic failure. We report a case of hepatocellular carcinoma with arterioportal shunt, successfully treated by TACE.

Search